Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Feb 18,2021
Analysis on the role of drug dissolution test in the determination of human bioavailability
The dissolution rate and extent of solid dosage forms such as tablets, capsules, or granules in a prescribed medium refer to the dissolution rate of the drug.
More
Analysis on the role of drug dissolution test in the determination of human bioavailability
Feb 18,2021
Humanization of antibody reduces the immunogenicity of antibody drugs
The application of antibodies has a history of hundreds of years. As a disease prevention, diagnosis and treatment agent, antibody drugs have undergone the development of murine antibodies, chimeric antibodies, humanized antibodies and fully humanized antibodies. Because the antibody drug is a kind of foreign protein, it is easy to activate the body's own immuneRead more
More
Humanization of antibody reduces the immunogenicity of antibody drugs
Feb 18,2021
Analysis of the role of affinity determination in the development of biological drugs
Drugs exert various pharmacological functions in vivo and in vitro by binding to the target, that is, interacting. Affinity (affinity) is a characteristic function of the relative state between candidate molecules, target molecular epitopes and candidate molecule-target molecule conjugates during the reversible reaction process, and can evaluate the strength of the binding between candidate moleculesRead more
More
Analysis of the role of affinity determination in the development of biological drugs
Feb 18,2021
Analysis on the method of immunogenicity detection of biotechnology drugs
Immunogenicity refers to the nature of drugs that stimulate the body to form specific antibodies or sensitized lymphocytes. In the development of biotechnology drugs, immunogenicity testing is an important task. For patients, immunogenicity will affect the safety and effectiveness of drugs, and even cause life-threatening dangers to patients because of the crossover of anti-drug antibodiesRead more
More
Analysis on the method of immunogenicity detection of biotechnology drugs
Feb 18,2021
You have never heard of the protein that can "melt" tumors!
Recently, cancer researchers at Vanderbilt discovered a new protein that, when genetically regulated to prevent it from interacting with the genes responsible for cancer, will effectively melt tumors within a few days. This exciting research result was recently published in eLife magazine. protein that can melt tumors You have never heard of the protein thatRead more
More
You have never heard of the protein that can "melt" tumors!
Feb 09,2021
BioNews| Hoth: Cooperate with Camargo to apply for HT-001 IND
Hoth Therapeutics, Inc. (HOTH) announced that it has entered into an agreement with Camargo PharmaticalServices to collaborate on the preparation of an investigational new drug application (IND) for HT-001 to be submitted to the U.S. Food and Drug Administration (FDA) to initiate the first clinical trial. Camargo collaborates with emerging biopharmaceutical companies to address unmetRead more
More
BioNews| Hoth: Cooperate with Camargo to apply for HT-001 IND
Feb 09,2021
Analysis of the potential target of lung cancer treatment-aquaporin 4
Lung cancer is one of the most harmful malignant tumors. To explore the pathogenesis of lung cancer and to find new targets for anti-tumor therapy are the hotspots and difficulties of current lung cancer treatment research. Studies have found that aquaporin 4 (AQP4) is highly expressed in lung cancer cells, and knocking down AQP4 canRead more
More
Analysis of the potential target of lung cancer treatment-aquaporin 4
Feb 09,2021
Analysis on the Role of Cytokine Detection in the Evaluation of Drug Treatment Effect
Cytokines that can regulate the physiological functions of a variety of cells are small molecular protein substances with biological activity secreted by cells. The concentration of cytokines and their receptors can reflect the pathological process of the disease. Through the detection of cytokines and the detection of the level of soluble receptors, the effects ofRead more
More
Analysis on the Role of Cytokine Detection in the Evaluation of Drug Treatment Effect
Feb 09,2021
Brief Introduction of the Relationship Between GM-CSF Cytokines And Immune diseases
Granulocyte-macrophage colony stimulating factor (GM-CSF) cytokine is an active immune effector factor with a wide range of immune activities in the body. As an immune adjuvant, it can not only promote the maturation of APCs (such as DC and macrophages) and improve its antigen presentation ability, but also play a role in T cell-mediated inflammatoryRead more
More
Feb 09,2021
Analysis of Three Verification Methods of Biological Sample Analysis
When conducting biomedical research, biological samples have the characteristics of less sampling, low drug concentration, endogenous substances, and individual differences. These factors may affect the determination of biological samples. Therefore, it is necessary to establish appropriate biological sample analysis methods. The verification of these biological analysis methods and the analysis of test samples should complyRead more
More
Analysis of Three Verification Methods of Biological Sample Analysis
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->